Background: Previous studies have demonstrated that Cardiac Shock Wave Therapy (CSWT) improves myocardial perfusion and cardiac function in a porcine model of chronic myocardial ischemia and also ameliorates myocardial ischemia in patients with severe coronary artery disease (CAD). Apoptosis plays a key role in ischemic myocardial pathogenesis. However, it cell apoptosis and by which mechanism CSWT could improve heart function. We put forward the hypothesis that CSWT might protect heart function during ischemia/hypoxia by decreasing apoptosis. Methods: We generated ischemia/hypoxia (I/H)-induced apoptosis in the H9c2 myoblast cell line to examine the CSWT function and possible mechanisms. H9c2 cells were treated under hypoxic serum-starved conditions for 24 h and then treated with or without CSWT (500 shots, 0.06, 0.09, 0.12mJ/mm 2 cytometry assay, cell viability was examined by the MTT assay, nuclear fragmentation was detected by Hoechst 33342 staining, and the mitochondrial-mediated intrinsic pathway of apoptosis was assessed by the expression of Bax and Bcl-2 protein and Caspase3 activation. Results: First, apoptosis could be induced by ischemia/hypoxia in H9c2 cells. Second, CSWT attenuates the cell death and decreases the H9c2 cell apoptosis rate induced by ischemia and hypoxia. Third, CSWT suppresses the expression of apoptosis molecules that regulate the intrinsic pathway of apoptosis in H9c2 cells. Fourth, CSWT increases the phosphorylation of AKT, which indicates the activation of the PI3K-AKT pathway. Conclusions: These results indicate that CSWT exerts a protective effect against I/H-induced cell death, potentially by preventing the activation of components of the mitochondrial-dependent intrinsic apoptotic pathway. We also demonstrate that the PI3K-Akt pathway may be involved in the CSWT effects on apoptosis.
Introduction
Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide [1] . The current therapeutic options are dependent on medical treatment, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). With these revascularization remains poor [3] . Therefore, it is crucial to develop alternative therapeutic strategies for these patients.
Cardiac Shock Wave Therapy (CSWT) is currently the most advanced technology developed in recent years. CSWT induces angiogenesis through the up-regulation of VEGF in ischemic myocardium and ameliorates myocardial ischemia and dysfunction in a porcine model of chronic myocardial ischemia, increasing myocardial perfusion and improving the patient's symptoms of angina and heart function [4] [5] [6] .
Apoptosis plays a key role in the pathogenesis of CAD due to the loss of myocardial cells. It has been reported that patients with end-stage congestive heart failure and myocardial infarction have higher rates of myocardial cell apoptosis than normal subjects [7] [8] [9] [10] . Apoptosis is a highly regulated program of cell death and can be mediated by two pathways, the extrinsic and intrinsic pathway, leading to Caspase activation. The cell death program is activated in myocardial cells by various apoptotic stimuli, including hypoxia, cytokines, increased oxidative stress, and DNA damage. Many studies have demonstrated that the inhibition of apoptosis can prevent the development of heart failure and improve heart function [11] [12] [13] [14] .
Recent studies have demonstrated that CSWT improves myocardial perfusion and cardiac function in a porcine model of chronic myocardial ischemia and also ameliorates myocardial ischemia in patients with severe CAD. Nonetheless, it is not clear whether CSWT the mechanisms by which CSWT could improve heart function. Based on the promising results from animal and clinical studies, we put forward the hypothesis that CSWT can model to test the effects of CSWT on apoptosis and to explore the possible mechanism of CSWT in improving myocardial function.
Materials and Methods

H9c2 cell culture
Simulated ischemia/hypoxia model or 48 h. (Fig. 1B-1C) , and less full-length caspase3 and more cleaved caspase3 was found compared to the NC group (Fig. induce apoptosis. or anti-apoptotic. Bax is an important factor leading to apoptosis under hypoxic stress. In response to apoptotic stimuli, Bax undergoes conformational activation and then facilitates suppress this Bax-induced release of cytochrome c from mitochondria [30, 31] . Hypoxia Bax was reported to determine cell survival or death following an apoptotic stimulus. Bax ischemia and hypoxia experiments to induce apoptosis. In our experiment, the viability of rate began to increase compared with the control cells, as indicated by increased Bax and It has been reported that the apoptosis induced by ischemia and hypoxia plays an important role in the development in CAD: the loss of myocardial cells causes abnormal studies have demonstrated that CSWT improves myocardial perfusion and cardiac function in a porcine model of chronic myocardial ischemia and also ameliorates myocardial ischemia in patients with severe CAD. In chronic ischemia animal experiments, it was observed that CSWT could induce a complete recovery of the left ventricular ejection fraction, wall thickening investigated whether CSWT had any effect on cardiomyocyte apoptosis in vitro. We observed apoptosis in cardiomyocytes.
Shock wave therapy
To further explore the regulation mechanism by which CSWT attenuates intracellular to growth, proliferation, and apoptosis inhibition, playing an important role in maintaining To date, several reports about shock wave application in experimental myocardial ischemia have been published, showing effectiveness in CAD. However, there also has some and functional loss of the myocardium [39, 40] . Given the lack of safety studies, an Italy study evaluates the safety of CSWT on the adult heart and its effects on cardiac tissue function and morphology. Four-month-old Fisher 344 rats were treated by CSWT. Cardiac function was measured by echocardiogram at baseline and at 1 and 3 months after treatment. The left ventricular ejection fraction and fractional shortening remained stable at all time points. apoptosis of cardiac cells in treated hearts in vivo 3 months after CSWT treatment [41] . Meanwhile, myocardial ischemia mini-pigs were used CSWT treated group compared to ischemia group by immunohistochemical staining at day observation, we think that CSWT is a safe and effective way to treat ischemic heart disease.
Several limitations should be mentioned for this study. First, although we were able to demonstrate that CSWT could attenuate myocardial cell apoptosis in vitro, the effects of CSWT in vivo cell death and demonstrate that this may occur by preventing the activation of components of the mitochondrial-dependent intrinsic apoptotic pathway. We also demonstrate that further work on this topic, our study demonstrates that CSWT is a prospective intervention for ischemic heart disease.
